# 바이오스페이스 일일 뉴스 리포트 - 2025년 06월 05일


## 주요 헤드라인

1. **Vigil’s TREM2 Antibody for Rare Brain Disease Flunks Phase II Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/vigils-trem2-antibody-for-rare-brain-disease-flunks-phase-ii-trial>

2. **Vigil’s TREM2 Antibody for Rare Brain Disease Flunks Phase II Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/vigils-trem2-antibody-for-rare-brain-disease-flunks-phase-ii-trial>

3. **Lilly Inks Deal Worth up to $870M To Develop Long-Acting GLP-1 Obesity Drugs (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-inks-deal-worth-up-to-870m-to-develop-long-acting-glp-1-obesity-drugs>

4. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/investing-in-research-and-welcoming-global-talent-strengthens-america>

5. **M&A Ticks Up, ASCO Excites and Vaccines Cause More Drama (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/m-a-ticks-up-asco-excites-and-vaccines-cause-more-drama>

6. **Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR-T Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/gilead-gears-up-to-challenge-j-j-in-20b-multiple-myeloma-car-t-market>

7. **Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR-T Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/gilead-gears-up-to-challenge-j-j-in-20b-multiple-myeloma-car-t-market>


---
*2025년 06월 05일 바이오스페이스 뉴스 피드에서 생성된 리포트*